The WHO Global Status Report on Alcohol and Health and Treatment of Substance Use Disorders provides a comprehensive snapshot of global trends in alcohol consumption, related harms, and national policy responses, alongside the availability and quality of treatment services for alcohol and drug use disorders.

Key Highlights:

• Presents the latest data from WHO Member States, aligned with SDG Health Target 3.5: “Strengthen prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.”

• Offers updated insights on global alcohol consumption patterns...

Background
Smoking is one of the top causes of preventable death and is linked to many serious health problems, including cancer and chronic diseases. Nurses can play a big role in helping people quit smoking by offering support through counselling, education, and mental health care. These nurse-led programs have been shown to increase quit rates. Training nurses to deliver these programs is important, and reviewing past studies helps us understand what works best.

Methods
Researchers searched eight major health databases between March 27 and August 1, 2024, to find studies on nurse-led...

EU Drug Market: Drivers and facilitators provides an overview of the key factors influencing the operation of the markets for illicit drugs in the European Union. It considers the changes and developments happening in the wider environment in which the illicit drug market is embedded (drivers), and the people or processes (facilitators) that make it easier to commit drug-related criminality or avoid detection. The focus of the report is on identifying key issues and presenting recommendations for action at EU and Member State level.

This resource is part of EU Drug Markets: In-depth analysis...

The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of national data across these themes, as well as on specialist drug treatment and key harm reduction interventions.

The purpose of the report is to provide an overview and summary of the European drug situation up to the end of 2023.

Background:
Digital mental health interventions for depression, anxiety, and stress-related disorders are generally cost-effective, but evidence is lacking for guided digital mental health care in low and middle-income countries (LMICs) facing humanitarian crises. Step-by-Step (SbS) is effective for Lebanese citizens and war-affected Syrians in Lebanon. Assessing SbS's cost-effectiveness is crucial due to Lebanon's strained health care system.

Objective:
This study aims to assess the cost-effectiveness of SbS compared to enhanced usual care (EUC) through a randomized trial.

Methods:
A cost...